...
首页> 外文期刊>International Journal of Cardiology >Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation
【24h】

Transthoracic echocardiographic backscatter-based assessment of left atrial remodeling involving left atrial and ventricular fibrosis in patients with atrial fibrillation

机译:经胸超声心动图基于背散射的左心房重构评估伴有心房颤动的左心房和心室纤维化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Left atrial (LA) fibrosis is a hallmark of atrial structural remodeling [1-3] and is related to recurrence after atrial fibrillation (AF) ablation, but the relationship to left ventricle (LV) fibrosis [4-6] remains unknown. Echocardiography-derived integrated backscatter (IBS) can noninvasively quantify myocardial fibrosis. Therefore, we used IBS to investigate whether a relationship exists between the LA and LV fibro-ses in AF and its impact on the post-ablation results. We studied 113 patients (mean age, 58.6 ± 9.7 years; 56 paroxysmal AF) who underwent their first catheter ablation of AF between September 2010 and January 2014 at Nihon University Itabashi Hospital. The exclusion criteria were: any valvular heart disease (moderate to severe state), LV contraction abnormality, LV hypertrophy, idiopathic cardiomyopathy, chronic pulmonary disease or thyroid disease. Randomly-selected patient records from our institution's echocardio-graphic database from May to August 2013, of 21 age- and sex-matched patients with no evidence of AF or heart disease, were accessed for the control data. All subjects signed a written informed consent, which was approved by the Institutional Review Board of Nihon Univerr sity Itabashi Hospital.
机译:左心房纤维化是心房结构重构的标志[1-3],与房颤消融后的复发有关,但与左心室纤维化的关系尚不清楚[4-6]。超声心动图衍生的集成背向散射(IBS)可以无创地量化心肌纤维化。因此,我们使用IBS来研究房颤中LA和LV纤维酶之间是否存在关系及其对消融后结果的影响。我们研究了2010年9月至2014年1月之间在日本大学板桥医院首次进行房颤消融的113例患者(平均年龄58.6±9.7岁;阵发性AF 56例)。排除标准为:任何瓣膜性心脏病(中度至重度状态),LV收缩异常,LV肥大,特发性心肌病,慢性肺部疾病或甲状腺疾病。我们从2013年5月至2013年8月从我们机构的超声心动图数据库中随机选择的21例年龄和性别匹配的无房颤或心脏病证据的患者记录作为对照数据。所有受试者均签署书面知情同意书,并获得日本大学板桥医院机构审查委员会的批准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号